𝔖 Bobbio Scriptorium

✦ LIBER ✦

Failure of sulfites to produce clinical responses in patients with systemic mastocytosis or recurrent anaphylaxis: Results of a single-blind study

✍ Scribed by MEGGS, W; ATKINS, F; WRIGHT, R; FISHMAN, M; KALINER, M; METCALFE, D

Book ID: 119057944
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 754 KB
Volume: 76
Category: Article
ISSN: 1097-6825
DOI: 10.1016/0091-6749(85)90758-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFICACY AND SAFETY OF TEVERELIX LA, A N

EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH

✍ C.M. Maclean; L. Skillern; F. Larsen; A. Gres; A. Strotski; A.V. Dmitrijev; V.K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A phase II randomized, double-blind, pla

A phase II randomized, double-blind, placebo-controlled multicenter study of recombinant human interleukin-12 for the treatment of chronic hepatitis C virus infection in patients non-responsive to previous treatment with interferon-alpha with or without ribavirin: Paul J Pockros, John G McHutchison, Scripps Clinic, La Jolla, CA; Chris O'Brien, University of Miami, Miami, FL; Myron Tong, Huntingon Medical Research Institute, Pasadena, CA; Coleman Smith, Minnesota Clinical Research Center, St. Paul, MN; Vinod Rustgi, Metropolitan Research Group, Fairfax, VA; Robert L Carithers, University of Washington Medical Center, Seattle, WA; Elizabeth Olek, Genetics Institute, Cambridge, MA

📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB